View source for Reference:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021 Appendix I

{{#set:
|HasDocument=Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021
|RefScope=G
|RefDocPart=Appendix I
|RefLanguage=EN
|RefTagsEN=
|RefTagsOriginal=
|RefTagsFR=
}}

== Document Information ==
{{:Document:EU EMA/698382/2021 - Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 2021}}

== Reference Details ==
{| class="wikitable" style="width:100%;"
|-
! scope="row" style="width:200px;" | Scope
| G
|-
! scope="row" style="width:200px;" | Document part
| Appendix I
|-
! scope="row" style="width:200px;" | Language
| EN
|-
! scope="row" style="width:200px;" | Original entry by
| Florian Adragna
|-
! scope="row" style="width:200px;" | Contributors
| 
|-
! scope="row" style="width:200px;" | Tags (EN)
| 
|-
! scope="row" style="width:200px;" | Tags (original language)
| 
|-
! scope="row" style="width:200px;" | Tags (FR)
| 
|-
! scope="row" | Comment
| Examples of serious breaches
|}

== Text ==
Appendix I – Examples of serious breaches